Interestingly, the extent of growth inhibition was particularly compelling when MCF-7 cells were cultured in media with charcoal-stripped sera, indicating that AFF4 is crucial for the growth of ER-positive breast cancer cells, and ablation of AFF4 may sensitize breast cancer cells to estrogen-deprived therapy. Here, AFF4 is linked to breast carcinoma.